Russia’s Sechenov University claims world’s first COVID-19 vaccine
At a time when pharma and biotech companies worldwide are racing to develop a vaccine, researchers at the University of
Read more
Clinical Trials
WHO declares second deadliest DR Congo Ebola outbreak is over
The World Health Organization (WHO) and the Democratic Republic of Congo (DRC) government announced on June 25 that the second-largest
Read more
Clover begins trials of COVID-19 vaccine with Dynavax and GSK adjuvants
The Chinese company Clover Biopharmaceuticals revealed the start of a randomized, double-blind, human stage Phase I placebo-controlled clinical study to
Read more
Corticosteroid Dexamethasone could be a lifeline for COVID-19 patients
The initial Dexamethasone clinical trial outcomes in the UK have demonstrated that the generic corticosteroid medication could present a lifeline
Read more
Reinstated hydroxychloroquine study reveals the dangers of rushed trials
The World Health Organisation (WHO) halted one arm of the hydroxychloroquine COVID-19 Trial at the end of May, only to
Read more
Algernon gets FDA nod for human study of Ifenprodil for COVID-19
Algernon has received the FDA’s approval for the commencement of a Phase 2 and 3 human study of it’s repurposed
Read more
AstraZeneca to advance Oxford’s COVID-19 vaccine with $1bn investment
AstraZeneca is going to expedite the development of the University of Oxford investigational COVID-19 vaccine with a $1 billion BARDA
Read more
Pfizer’s gene therapy promising for Duchenne muscular dystrophy (DMD)
Pfizer Inc. has revealed revised clinical Phase 1b results on PF-06939926, an investigational gene therapy to treat Duchenne muscular dystrophy
Read more
ACTide EDC (Electronic Data Capture) System against COVID-19
Nubilaria, a forward thinking clinical data management company, has released an important announcement for Researchers and Health Professionals in Europe
Read more
FDA clears Deciphera Pharmaceuticals’ QINLOCK™ (ripretinib) for GIST
Deciphera Pharmaceuticals, Inc. has revealed that QINLOCK™ (ripretinib) was formally authorised by the U.S. Food and Drug Administration (FDA) for
Read more